Otsuka Pharmaceutical announced that the FDA is reviewing investigational centanafadine -- a potential first-in-class ...
For papers submitted to JAMA Network journals, the most commonly disclosed use of AI was for correction or refinement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results